Three companies face US fraud lawsuits
October 24, 2003Three pharmaceutical companies, GlaxoSmithKline, Pharmacia and Aventis, face legal action for alleged bribery and inflation of prescription drug prices in …
Smaller hospitals win Government support
October 24, 2003Smaller local hospitals are to become important centres for developing patient-centred care in a reversal of what the Government calls …
14 more PCTs to join pharmaceutical services revolution
October 24, 2003Fourteen PCTs have been given the go-ahead to develop new and innovative services and improve patient services through community pharmacists.Local …
J&J strengthens biotech business
October 24, 2003Janssen, Janssen Cilag, Johnson & Johnson, Scios
Johnson & Johnson is to expand its biotech capabilities with a $2.4 billion purchase of US company Scios.The deal, still …
vCJD caution prompts Serono product withdrawal
October 24, 2003Serono is to withdraw one of its hormone products from the UK after a case of variant Creutzfeldt-Jakob disease was …
Iressa filed in Europe amid safety concerns
October 24, 2003AstraZeneca has submitted its lung cancer drug Iressa for approval in Europe, despite concerns about side-effects.The novel drug was launched …
New trial for treatment-resistant HIV
October 24, 2003Boehringer Ingelheim has begun a global phase III trial for a new drug it hopes will be effective for HIV …
Former ImClone chief fined $800,000 for insider dealing
October 24, 2003Former ImClone boss Samuel Waksal has agreed to pay $800,000 to settle some of the charges brought against him by …
GSK puts new slant on Garnier pay battle
October 24, 2003GlaxoSmithKline is to raise the issue of Chief Executive Jean-Pierre Garnier's pay once again this week, saying it is intended …
EU to conclude Pfizer-Pharmacia review in coming weeks
October 24, 2003The European Commission has restarted its review of Pfizer's merger with Pharmacia, and now expects to complete the investigation of …
Conflict of interests halt Seroxat inquiry
October 24, 2003If you were to ask leading CRO executives they would tell you that blue chip pharma companies outsource their critical …
AstraZeneca files first for European bipolar disorder
October 24, 2003AstraZeneca have filed the first European marketing application for an atypical antipsychotic as a treatment for manic episodes related to …
Lilly’s well-planned campaign launches ‘spontaneity’ ED drug
October 24, 2003Eli Lilly have launched Cialis, the first serious rival to blockbuster erectile dysfunction drug Viagra amid a flurry of media …
Aventis cautious as growth slows
October 24, 2003Aventis has reined in its 2003 forecasts and warned investors that the pace of its growth would slow to a …
Elan shows $2.4bn loss for 2002
October 24, 2003Irish pharmaceutical company Elan made a larger than expected loss of $2.39 billion last year.Shares in the troubled company fell …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
